Vitality Biopharma Inc. | Income Statement
Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
245.70
248.30
163.40
102.40
Cost of Goods Sold (COGS) incl. D&A
-
121.30
149.50
108.30
77.90
Gross Income
-
124.30
98.90
55.10
24.50
SG&A Expense
3,597.60
3,929.50
2,840.60
3,526.70
4,421.20
EBIT
3,597.60
3,805.20
2,741.80
3,471.60
4,396.80
Unusual Expense
150.90
237.20
2,600.80
1,746.80
87.70
Non Operating Income/Expense
-
-
-
1.00
-
Interest Expense
404.30
6.10
0.40
-
-
Pretax Income
4,152.80
4,048.40
141.30
5,219.40
4,309.00
Consolidated Net Income
4,152.80
4,048.40
141.30
5,219.40
4,309.00
Net Income
4,152.80
4,048.40
141.30
5,219.40
4,309.00
Net Income After Extraordinaries
4,152.80
4,048.40
141.30
5,219.40
4,309.00
Net Income Available to Common
4,152.80
4,048.40
141.30
5,219.40
4,309.00
EPS (Basic)
0.70
0.60
0.02
0.38
0.19
Basic Shares Outstanding
6,012.80
7,042.20
7,542.00
13,591.10
23,121.00
EPS (Diluted)
0.69
0.57
0.02
0.38
0.19
Diluted Shares Outstanding
6,012.80
7,042.20
7,542.00
13,591.10
23,121.00
EBITDA
3,597.60
3,805.20
2,741.80
3,471.60
4,396.80
About Vitality Biopharma
View Profile
